Arta Monir Monjazeb

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme
    Arta M Monjazeb
    Department of Radiation Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 82:743-8. 2012
  2. doi request reprint The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications
    Arta Monir Monjazeb
    Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA 95816, USA
    Semin Radiat Oncol 23:60-73. 2013

Detail Information

Publications2

  1. doi request reprint A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme
    Arta M Monjazeb
    Department of Radiation Oncology, UC Davis School of Medicine, Sacramento, CA 95817, USA
    Int J Radiat Oncol Biol Phys 82:743-8. 2012
    ..To describe the results of a Phase I dose escalation trial for newly diagnosed glioblastoma multiforme (GBM) using a hypofractionated concurrent intensity-modulated radiotherapy (IMRT) boost...
  2. doi request reprint The impact of multimodality therapy of distal esophageal and gastroesophageal junction adenocarcinomas on treatment-related toxicity and complications
    Arta Monir Monjazeb
    Department of Radiation Oncology, UC Davis Comprehensive Cancer Center, Sacramento, CA 95816, USA
    Semin Radiat Oncol 23:60-73. 2013
    ..Late toxicities are less well defined, but commonly include esophageal, pulmonary, and cardiac toxicities...